Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma
Ganglioneuroblastoma Localized Resectable Neuroblastoma Localized Unresectable Neuroblastoma Regional Neuroblastoma Stage 4 Neuroblastoma Stage 4S Neuroblastoma Neuroblastoma Cytology Specimen Collection Procedure Laboratory Biomarker Analysis Ancillary-Correlative (cytology specimen collection)
Lead Scientists at University of California Health
- Tom B. Davidson (ucla)
- Carla B. Golden (ucsf)
- Michael D. Hogarty (uci)
- Marcio H. Malogolowkin (ucdavis)
Professor, Pediatrics. Authored (or co-authored) 98 research publications.
- Katherine K. Matthay (ucsf)
Dr. Katherine Matthay is the chief of Pediatric Hematology-Oncology at UCSF Benioff Children's Hospital and has been focused for more than 20 years on translational research in neuroblastoma, a deadly childhood cancer. At UCSF, she has developed and led multiple trials using a unique targeted radiopharmaceutical, 131I-MIBG for neuroblastoma.
- Eduard H. Panosyan (ucla)
HS Associate Clinical Professor, Pediatrics. Authored (or co-authored) 24 research publications.
- accepting new patients
- Start Date
- Children's Oncology Group
- Study Type
- Last Updated